BNP Paribas Financial Markets
ORIC icon

BNP Paribas Financial Markets’s Oric Pharmaceuticals ORIC Stock Holding History

BNP Paribas Financial Markets’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74M Buy
345,038
+323,937
+1,535% +$2.94M ﹤0.01% 2330
2026
Q1 		$267K Sell
21,101
-19,014
-47% -$216K ﹤0.01% 3915
2025
Q4 		$328K Sell
40,115
-198,505
-83% -$2.28M ﹤0.01% 3809
2025
Q3 		$2.86M Buy
238,620
+151,865
+175% +$1.6M ﹤0.01% 2353
2025
Q2 		$881K Buy
86,755
+79,540
+1,102% +$534K ﹤0.01% 2984
2025
Q1 		$40.3K Sell
7,215
-1,586
-18% -$13.9K ﹤0.01% 4358
2024
Q4 		$71K Buy
+8,801
New +$80.8K ﹤0.01% 4298
2022
Q4 		– Sell
-845
Closed -$2.7K – 4440
2022
Q3 		$2.7K Buy
+845
New +$3.38K ﹤0.01% 4316

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BNP Paribas Financial Markets's ORIC Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Oric Pharmaceuticals (ORIC) stake by 1,535% in Q2 2026, buying an estimated $2.94M and bringing the position to 345,038 shares worth $3.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2330.

BNP Paribas Financial Markets first reported a position in ORIC in Q3 2022 and has held it in 8 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • BNP Paribas Financial Markets held 345,038 shares of Oric Pharmaceuticals worth $3.74M as of Q2 2026.
  • BNP Paribas Financial Markets bought 323,937 Oric Pharmaceuticals shares in Q2 2026, an estimated $2.94M.
  • Oric Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2330 holding.
  • BNP Paribas Financial Markets first reported a position in Oric Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.